144 related articles for article (PubMed ID: 14744603)
1. Participation of the L-arginine-nitric oxide-cyclic GMP-ATP-sensitive K+ channel cascade in the antinociceptive effect of rofecoxib.
Déciga-Campos M; López-Muñoz FJ
Eur J Pharmacol; 2004 Jan; 484(2-3):193-9. PubMed ID: 14744603
[TBL] [Abstract][Full Text] [Related]
2. Participation of the nitric oxide-cyclic GMP-ATP-sensitive K(+) channel pathway in the antinociceptive action of ketorolac.
Lázaro-Ibáñez GG; Torres-López JE; Granados-Soto V
Eur J Pharmacol; 2001 Aug; 426(1-2):39-44. PubMed ID: 11525769
[TBL] [Abstract][Full Text] [Related]
3. [Involvement of L-arginine-nitric oxide-cyclic GMP pathway in the peripheral antinociceptive effect induced by parecoxib].
Martínez-Quiroz ZI; López-Muñoz FJ; Guevara-López UM
Cir Cir; 2005; 73(2):119-25. PubMed ID: 15910705
[TBL] [Abstract][Full Text] [Related]
4. The nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway participates in the antiallodynic effect of spinal gabapentin.
Mixcoatl-Zecuatl T; Flores-Murrieta FJ; Granados-Soto V
Eur J Pharmacol; 2006 Feb; 531(1-3):87-95. PubMed ID: 16438951
[TBL] [Abstract][Full Text] [Related]
5. The NO-cGMP-K+ channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin.
Ortiz MI; Granados-Soto V; Castañeda-Hernández G
Pharmacol Biochem Behav; 2003 Aug; 76(1):187-95. PubMed ID: 13679232
[TBL] [Abstract][Full Text] [Related]
6. Role of nitric oxide/cyclic GMP/K(+) channel pathways in the antinociceptive effect caused by 2,3-bis(mesitylseleno)propenol.
Jesse CR; Savegnago L; Nogueira CW
Life Sci; 2007 Dec; 81(25-26):1694-702. PubMed ID: 18031763
[TBL] [Abstract][Full Text] [Related]
7. Possible participation of the nitric oxide-cyclic GMP-protein kinase G-K+ channels pathway in the peripheral antinociception of melatonin.
Hernández-Pacheco A; Araiza-Saldaña CI; Granados-Soto V; Mixcoatl-Zecuatl T
Eur J Pharmacol; 2008 Oct; 596(1-3):70-6. PubMed ID: 18755181
[TBL] [Abstract][Full Text] [Related]
8. Possible activation of the NO-cyclic GMP-protein kinase G-K+ channels pathway by gabapentin on the formalin test.
Ortiz MI; Medina-Tato DA; Sarmiento-Heredia D; Palma-Martínez J; Granados-Soto V
Pharmacol Biochem Behav; 2006 Mar; 83(3):420-7. PubMed ID: 16630650
[TBL] [Abstract][Full Text] [Related]
9. Participation of the opioid receptor - nitric oxide - cGMP - K
Ortiz MI; Cariño-Cortés R; Castañeda-Hernández G
Can J Physiol Pharmacol; 2020 Nov; 98(11):753-762. PubMed ID: 33095677
[TBL] [Abstract][Full Text] [Related]
10. The peripheral L-arginine-nitric oxide-cyclic GMP pathway and ATP-sensitive K⁺ channels are involved in the antinociceptive effect of crotalphine on neuropathic pain in rats.
Gutierrez VP; Zambelli VO; Picolo G; Chacur M; Sampaio SC; Brigatte P; Konno K; Cury Y
Behav Pharmacol; 2012 Feb; 23(1):14-24. PubMed ID: 22126967
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway in the antihyperalgesic effects of bovine lactoferrin in a model of neuropathic pain.
Wang J; Zhang LC; Lv YW; Ji Y; Yan XJ; Xue JP
Brain Res; 2008 May; 1209():1-7. PubMed ID: 18406400
[TBL] [Abstract][Full Text] [Related]
12. Role of l-arginine/SNAP/NO/cGMP/K
Safaripour S; Nemati Y; Parvardeh S; Ghafghazi S; Fouladzadeh A; Moghimi M
J Pharm Pharmacol; 2018 Apr; 70(4):507-515. PubMed ID: 29380385
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive effect of nimesulide.
Islas-Cadena M; Aguirre-Bañuelos P; Granados-Soto V
J Pharmacol Toxicol Methods; 1999 Oct; 42(2):87-92. PubMed ID: 10924891
[TBL] [Abstract][Full Text] [Related]
14. Involvement of L-arginine/NO/cGMP/K(ATP) channel pathway in the peripheral antinociceptive actions of ellagic acid in the rat formalin test.
Ghorbanzadeh B; Mansouri MT; Hemmati AA; Naghizadeh B; Mard SA; Rezaie A
Pharmacol Biochem Behav; 2014 Nov; 126():116-21. PubMed ID: 25278343
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive action of meloxicam in the formalin test.
Aguirre-Bañuelos P; Granados-Soto V
Eur J Pharmacol; 2000 Apr; 395(1):9-13. PubMed ID: 10781667
[TBL] [Abstract][Full Text] [Related]
16. Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats.
Araiza-Saldaña CI; Reyes-García G; Bermúdez-Ocaña DY; Pérez-Severiano F; Granados-Soto V
Eur J Pharmacol; 2005 Dec; 527(1-3):60-70. PubMed ID: 16305795
[TBL] [Abstract][Full Text] [Related]
17. L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway.
Duarte ID; Ferreira SH
Mediators Inflamm; 2000; 9(1):25-30. PubMed ID: 10877451
[TBL] [Abstract][Full Text] [Related]
18. Participation of the GABA/benzodiazepine receptor and the NO-cyclicGMP pathway in the "antinociceptive-like effects" of diazepam.
Jiménez-Velázquez G; López-Muñoz FJ; Fernández-Guasti A
Pharmacol Biochem Behav; 2008 Nov; 91(1):128-33. PubMed ID: 18638499
[TBL] [Abstract][Full Text] [Related]
19. Peripheral involvement of the nitric oxide-cGMP pathway in the indomethacin-induced antinociception in rat.
Ventura-Martínez R; Déciga-Campos M; Díaz-Reval MI; González-Trujano ME; López-Muñoz FJ
Eur J Pharmacol; 2004 Oct; 503(1-3):43-8. PubMed ID: 15496294
[TBL] [Abstract][Full Text] [Related]
20. Role of the NO-cGMP-K
Ortiz MI; Cariño-Cortés R; Muñoz-Pérez VM; Salas-Casas A; Castañeda-Hernández G
Can J Physiol Pharmacol; 2021 Oct; 99(10):1048-1056. PubMed ID: 33857384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
